医学
盒内非相干运动
有效扩散系数
神秘的
磁共振成像
接收机工作特性
放射科
核医学
磁共振弥散成像
优势比
病理
内科学
替代医学
作者
Fangqing Wang,Xinghua Xu,Yinghui Chen,Jianwei Xu,Weiwei Ji,Dexin Yu
摘要
BACKGROUND: Occult liver metastases in patients with pancreatic ductal adenocarcinoma (PDAC) affects treatment strategies and prognosis. Diffusion-weighted imaging (DWI), including non-Gaussian DWI may help to evaluate tumor biological behavior. PURPOSE: To evaluate the diagnostic value of DWI parameters in predicting occult liver metastases in patients with PDAC. STUDY TYPE: Prospective. POPULATION: 115 participants with pathologically confirmed PDAC (male = 71, mean age = 59.8 ± 9.9 years). Occult liver metastasis was defined as those detected by CT or MRI within 6 months of pancreatectomy. FIELD STRENGTH/SEQUENCE: DWI, intravoxel incoherent motion (IVIM) imaging and diffusion kurtosis imaging (DKI) echo planar imaging sequences at 1.5 T. ASSESSMENT: Apparent diffusion coefficient (ADC), pure diffusion coefficient (D), pseudo-diffusion coefficient (D*), perfusion fraction (f), mean apparent diffusion (MD) and mean kurtosis (MK) were measured. In addition, age, sex, body mass index, neutrophil-to-lymphocyte ratio (NLR) and carbohydrate antigen 19-9 (CA 19-9) level were recorded. STATISTICAL TESTS: Logistic regression analysis, area under the receiver operating characteristic curve (AUC), DeLong test. Two tailed P value < 0.05 was considered significant. Results 23 of 115 (20%) participants had occult liver metastases. Multivariable analysis revealed D [odds ratio (OR) = 0.220], NLR (OR = 1.391) and CA19-9 level (OR = 1.002) were independent risk factors for occult liver metastases. The AUCs were 0.772 for the combination of NLR and CA19-9 level, and 0.848 for the combination of D, NLR and CA19-9 level, without significant difference between the two models (P = 0.055). DATA CONCLUSION: A combination of D, NLR and CA19-9 level may be useful in the prediction of occult liver metastases in patients with PDAC. EVIDENCE LEVEL: 2. TECHNICAL EFFICACY: Stage 2.
科研通智能强力驱动
Strongly Powered by AbleSci AI